Increased rates of periprosthetic joint infection in patients with cirrhosis undergoing total joint arthroplasty

Clinical Orthopaedics and Related Research

Volumn 472, Issue 8, 2014, Pages 2483-2491

  Jiang, Shirley L ^a   Schairer, William W ^a   Bozic, Kevin J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; HIP ARTHROPLASTY; HIP FRACTURE; HOSPITAL CHARGE; HOSPITAL READMISSION; HUMAN; INFECTION RATE; INFECTION RISK; LENGTH OF STAY; LIVER CIRRHOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; THROMBOCYTE; TOTAL JOINT ARTHROPLASTY; TOTAL KNEE REPLACEMENT; UNITED STATES;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HEALTH CARE COSTS; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATIENT READMISSION; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84904091146     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-014-3593-y     Document Type: Article

References (31)

1. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746-1751. (Pubitemid 41061193)
2. Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA. 1996;275:858-865. (Pubitemid 26087223)
3. Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102:1510-1517. (Pubitemid 46976304)
4. Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty. 2005;20:460-466. (Pubitemid 40804451)
5. Cram P, Lu X, Kaboli PJ, Vaughan-Sarrazin MS, Cai X, Wolf BR, Li Y. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA. 2011;305:1560-1567.
6. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27. (Pubitemid 128456396)
7. HCUP NIS Database Documentation. Healthcare Cost and Utilization Project (HCUP). December 2013. Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp. Accessed March 19, 2014.
8. HCUP Databases. Healthcare Cost and Utilization Project (HCUP). December 2013. Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.hcup-us.ahrq.gov/sidoverview.jsp. Accessed March 19, 2014.
9. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician. 2006;74:756-762.
10. Hsieh PH, Ueng SW, Lee MS, Shih HN, Huang KC. Prosthetic hip infection in patients with liver cirrhosis: an outcome analysis. Int J Infect Dis. 2010;14:e1054-1059.
11. Jimenez-Garcia R, Villanueva-Martinez M, Fernandez-de-Las-Penas C, Hernandez-Barrera V, Rios-Luna A, Garrido PC, de Andres AL, Jimenez-Trujillo I, Montero JS, Gil-de-Miguel A. Trends in primary total hip arthroplasty in Spain from 2001 to 2008: evaluating changes in demographics, comorbidity, incidence rates, length of stay, costs and mortality. BMC Musculoskelet Disord. 2011;12:43.
12. Koenig K, Huddleston JI 3rd, Huddleston H, Maloney WJ, Goodman SB. Advanced age and comorbidity increase the risk for adverse events after revision total hip arthroplasty. J Arthroplasty. 2012;27:1402-1407e1.
13. Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am. 2005;87:1487-1497. (Pubitemid 40917748)
14. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785. (Pubitemid 46564282)
15. Lavernia CJ, Guzman JF, Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res. 1997;345:134-139. (Pubitemid 28007495)
16. Losina E, Thornhill TS, Rome BN, Wright J, Katz JN. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am. 2012;94:201-207.
17. Meehan JP, Danielsen B, Tancredi DJ, Kim S, Jamali AA, White RH. A population-based comparison of the incidence of adverse outcomes after simultaneous-bilateral and staged-bilateral total knee arthroplasty. J Bone Joint Surg Am. 2011;93:2203-2213.
18. Millwala F, Nguyen GC, Thuluvath PJ. Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management. World J Gastroenterol. 2007;13:4056-4063. (Pubitemid 47323157)
19. Moon YW, Kim YS, Kwon SY, Kim SY, Lim SJ, Park YS. Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease. J Korean Med Sci. 2007;22:223-226.
20. Orozco F, Post ZD, Baxi O, Miller A, Ong A. Fibrosis in Hhpatitis C patients predicts complications after elective total joint arthroplasty. J Arthroplasty. 2014;29:7-10.
21. Peak EL, Hozack WJ, Sharkey PF, Parvizi J, Rothman RH. One-stage bilateral total joint arthroplasty: a prospective, comparative study of total hip and total knee replacement. Orthopedics. 2008;31:131.
22. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 1984;4:53-58. (Pubitemid 14185424)
23. Schairer WW, Sing DC, Vail TP, Bozic KJ. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthop Relat Res. 2014;472:464-470.
24. Schairer WW, Vail TP, Bozic KJ. What are the rates and causes of hospital readmission after total knee arthroplasty? Clin Orthop Relat Res. 2014;472:181-187.
25. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. (Pubitemid 351323895)
26. Shih LY, Cheng CY, Chang CH, Hsu KY, Hsu RW, Shih HN. Total knee arthroplasty in patients with liver cirrhosis. J Bone Joint Surg Am. 2004;86:335-341. (Pubitemid 38141569)
27. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW; Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4):1-32.
28. Talwalkar JA. Time trends in hospitalization and discharge status for cirrhosis and portal hypertension in the United States. Hepatology. 2010;52:1862; author reply 1863.
29. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. Available at: http://www.bls.gov/cpi/superlink.htm. Accessed March 19, 2014,
30. Wolf BR, Lu X, Li Y, Callaghan JJ, Cram P. Adverse outcomes in hip arthroplasty: long-term trends. J Bone Joint Surg Am. 2012;94:e103.
31. Ziser A, Plevak DJ. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Curr Opin Anaesthesiol. 2001;14:707-711. (Pubitemid 33135725)